INTRODUCTION
Attachment of Mycoplasma pneumoniae to mucosal tissues is an essential step in initiating respiratory disease and may help to protect the mycoplasma from the defense mechanisms of the host. Stimulation of host immune responses to mycoplasma binding components should inhibit infection and provide an effective means of preventing disease [1] . A protein-rich extract of M. pneumoniae which exhibits binding activity [2] is a potential source for the purification and characterization of M. pneumoniae binding components. Comparative studies showed that virulent strains of M. pneumoniae readily attach to hamster tracheal organ cultures, tracheal outgrowth monolayers, human erythrocytes, and WiDr human carcinoma cell cultures [3] . However, the WiDr cell culture monolayers provided the most useful cell substrate for quantitating attachment inhibition. This report summarizes the WiDr monolayer micro-attachment assay and describes two applications of the procedure: a quantitative assay for mycoplasmal binding components based on inhibition by the protein-rich extract, and characterization of target cell receptor activities based on inhibition by gangliosides and sialic acid-containing glycoproteins.
MATERIALS AND METHODS
M. pneumoniae cultures were grown and labeled with 3H-palmitic acid as previously described [3, 4] . The micro-attachment assay utilized human carcinoma WiDr cell cultures on 5 mm coverslips (105 cells per microtiter well) as previously described [4] . The WiDr cell monolayers were incubated at 36°C with 5-80,tg of radiolabeled M. pneumoniae cell protein for one hour, the monolayers were washed, [3] , and procedures were developed for using cell culture monolayers in the assays. WiDr cells from a human intestinal carcinoma were selected because they are of human origin and are epithelial-like [5] . A number of cell cultures were screened for M. pneumoniae attachment using a DNA staining procedure [6] , and comparative studies indicated that the WiDr cell line was superior for M. pneumoniae attachment. The time course for the attachment of M.
pneumoniae to the WiDr cell monolayers at 36°C showed that binding occurred in one hour, while background attachment to control coverslips without cells was less than 10 percent of the attachment to the monolayers [3] . An incubation time of one hour was used in the standard attachment assay.
The micro-attachment assay was used to examine the attachment capacity of radiolabeled strains PI-1428, M129, MAC, FH, and B176 [7] . Inhibition studies were performed by preincubating the WiDr monolayers with unlabeled M. pneumoniae or the protein-rich extract. Radiolabeled M. pneumoniae was then added as described for the standard attachment assay. The capacity of unlabeled M. pneumoniae to inhibit attachment of 3H-M. pneumoniae was examined. When the WiDr monolayers were preincubated with equivalent amounts of unlabeled organisms, subsequent attachment of radiolabeled mycoplasmas was inhibited by 50 to 60 percent [4] .
We have described a protein-rich extract of M. pneumoniae which has the capacity to agglutinate human erythrocytes [2] . The extract was prepared by incubating M. pneumoniae with 2 M NaCl followed by freeze-thaw, ultracentrifugation, and dialysis and lyophilization of the supernatant [2] . The hemagglutinating activity of the extract indicates that it contains solubilized mycoplasma binding components which should inhibit attachment. Figure 1 demonstrates that M. pneumoniae attachment was progressively inhibited with increasing levels of the protein-rich extract. To calculate binding component activity, the attachment in the presence of extract was subtracted from the control value obtained without extract, as illustrated in Fig.  1 [3] Thus, the micro-attachment assay provides the appropriate mycoplasma/receptor site ratio for quantitative inhibition studies. It is noteworthy that the hyperbolic attachment curves obtained with the mycoplasmal binding components as well as with the intact cells approximate the Langmuir adsorption isotherms expected for receptor-ligand binding [10] .
Moreover, the Lineweaver-Burke double reciprocal plots of the binding data from these curves were linear [Chandler DKF: unpublished results]. These observations provide further evidence that the attachment of radiolabeled mycoplasmas and the attachment inhibition by binding components in the extract represent specific interactions with receptor components of the WiDr cells. Attachment Inhibition: Detection of Target Cell Receptor Analogues Attachment inhibition was also observed when the radiolabeled M. pneumoniae was treated with certain select sialoglycoconjugates. Figure 2 shows the results of two experiments in which we examined attachment inhibition by transferrin, ovalbumin, orosomucoid, gangliosides, and ceruloplasmin. Inhibition by transferrin and ovalbumin was less than 20 percent, while attachment inhibition by orosomucoid and gangliosides was 57 percent and 82 percent, respectively. In the second experiment, the dose response for ceruloplasmin shows progressive inhibition with increasing concentration (data plotted from [4] ).
Previous work has indicated that receptor sites on the host cell surface comprise sialic acid-containing glycoconjugates [11] [12] [13] [14] [15] [16] . Attachment of M. pneumoniae to WiDr cells was inhibited by gangliosides, ceruloplasmin, and orosomucoid, which supports this concept of the host cell receptor. Gangliosides, ceruloplasmin, and orosomucoid are sialoglycoconjugates which may contain structural analogues of the specific cell receptors that bind to the mycoplasmas, thereby blocking attachment to target cells. Hence, the relative binding activities of these and other sialoglycoconjugates may also provide information about the specificity of the receptor sites. CONCLUSIONS The WiDr cell monolayer micro-attachment assay provides the appropriate mycoplasma/receptor site ratio for quantitative inhibition studies and binding 682 analyses. Mycoplasmal binding components in a protein-rich extract of M. pneumoniae can be quantitated using the attachment inhibition assay, and the extract presents a suitable source for the characterization and purification of the binding components. The WiDr cell monolayer attachment inhibition assay can also identify host cell receptor activities. Thus, the WiDr cell culture monolayers provide an important in vitro model to examine M. pneumoniae attachment mechanisms.
